Recombinant Human Chorionic Gonadotropin - Global and China Top Players Market Share and Ranking 2023
Recombinant Human Chorionic Gonadotropin - Global and China Top Players Market Share and Ranking 2023
The Recombinant Human Chorionic Gonadotropin study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest study , the global market for Recombinant Human Chorionic Gonadotropin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Recombinant Human Chorionic Gonadotropin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Recombinant Human Chorionic Gonadotropin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Female grew percent to account for percent of the total market sales, and Male grew percent.
This report studies and analyses global Recombinant Human Chorionic Gonadotropin status and future trends, helps the client to determine the Recombinant Human Chorionic Gonadotropin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Recombinant Human Chorionic Gonadotropin, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Recombinant Human Chorionic Gonadotropin market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Recombinant Human Chorionic Gonadotropin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Recombinant Human Chorionic Gonadotropin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Recombinant Human Chorionic Gonadotropin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Recombinant Human Chorionic Gonadotropin key producing regions, capacity, production, and year over year growth
(6) Recombinant Human Chorionic Gonadotropin industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Ferring Pharmaceuticals
Schering Plough
Serum International Ltd
Merck
Wellona Pharma
Bionomics Lifesciences
Marvel Oceanic Private Limited
Facmed Pharmaceuticals
Market segment by Type, covers
Intramuscular Powder for Injection
Subcutaneous Solution for Injection
Market segment by Application, can be divided into
Female
Male
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Recombinant Human Chorionic Gonadotropin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Recombinant Human Chorionic Gonadotropin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Recombinant Human Chorionic Gonadotropin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Recombinant Human Chorionic Gonadotropin, percent & CAGR, 2018-2029
Chapter 5: Recombinant Human Chorionic Gonadotropin industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Recombinant Human Chorionic Gonadotropin Definition
1.2 Global Recombinant Human Chorionic Gonadotropin Market Size and Forecast
1.2.1 By Consumption Value, Global Recombinant Human Chorionic Gonadotropin Market Size，2018-2029
1.2.2 By Sales Quantity, Global Recombinant Human Chorionic Gonadotropin Market Size，2018-2029
1.2.3 Global Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP)，2018-2029
1.3 China Recombinant Human Chorionic Gonadotropin Market Size and Forecast
1.3.1 By Consumption Value, China Recombinant Human Chorionic Gonadotropin Market Size，2018-2029
1.3.2 By Sales Quantity, China Recombinant Human Chorionic Gonadotropin Market Size，2018-2029
1.3.3 China Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP)， 2018-2029
1.4 Share of China Recombinant Human Chorionic Gonadotropin Market with Respect to the Global Market
1.4.1 By Consumption Value, China Recombinant Human Chorionic Gonadotropin Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Recombinant Human Chorionic Gonadotropin Market Share in Global, 2018-2029
1.4.3 Recombinant Human Chorionic Gonadotropin Market Size: China VS Global, 2018-2029
1.5 Recombinant Human Chorionic Gonadotropin Market Dynamics
1.5.1 Recombinant Human Chorionic Gonadotropin Market Drivers
1.5.2 Recombinant Human Chorionic Gonadotropin Market Restraints
1.5.3 Recombinant Human Chorionic Gonadotropin Industry Trends
1.5.4 Recombinant Human Chorionic Gonadotropin Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Recombinant Human Chorionic Gonadotropin, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Recombinant Human Chorionic Gonadotropin, Global Market Share by Company, 2018-2023
2.3 Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Recombinant Human Chorionic Gonadotropin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Recombinant Human Chorionic Gonadotropin Concentration Ratio
2.6 Global Recombinant Human Chorionic Gonadotropin Mergers & Acquisitions, Expansion Plans
2.7 Global Recombinant Human Chorionic Gonadotropin Manufacturers Product Type
2.8 Head Office and Recombinant Human Chorionic Gonadotropin Production Site of Key Manufacturer
2.9 Recombinant Human Chorionic Gonadotropin Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Recombinant Human Chorionic Gonadotropin, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Recombinant Human Chorionic Gonadotropin, China Market Share by Company, 2018-2023
3.3 China Recombinant Human Chorionic Gonadotropin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Recombinant Human Chorionic Gonadotropin Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Recombinant Human Chorionic Gonadotropin Capacity by Region
4.3 Global Recombinant Human Chorionic Gonadotropin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Recombinant Human Chorionic Gonadotropin Production by Region, 2018-2029
4.5 Global Recombinant Human Chorionic Gonadotropin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Recombinant Human Chorionic Gonadotropin Industry Chain
5.2 Recombinant Human Chorionic Gonadotropin Upstream Analysis
5.2.1 Recombinant Human Chorionic Gonadotropin Core Raw Materials
5.2.2 Main Manufacturers of Recombinant Human Chorionic Gonadotropin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Recombinant Human Chorionic Gonadotropin Production Mode
5.6 Recombinant Human Chorionic Gonadotropin Procurement Model
5.7 Recombinant Human Chorionic Gonadotropin Industry Sales Model and Sales Channels
5.7.1 Recombinant Human Chorionic Gonadotropin Sales Model
5.7.2 Recombinant Human Chorionic Gonadotropin Typical Distributors
6 Sights by Type
6.1 Recombinant Human Chorionic Gonadotropin Classification
6.1.1 Intramuscular Powder for Injection
6.1.2 Subcutaneous Solution for Injection
6.2 By Type, Global Recombinant Human Chorionic Gonadotropin Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029
6.4 By Type, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029
6.5 By Type, Global Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Recombinant Human Chorionic Gonadotropin Segment by Application
7.1.1 Female
7.1.2 Male
7.2 By Application, Global Recombinant Human Chorionic Gonadotropin Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029
7.4 By Application, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029
7.5 By Application, Global Recombinant Human Chorionic Gonadotropin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029
8.3 By Region, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Recombinant Human Chorionic Gonadotropin & Forecasts, 2018-2029
8.4.2 By Country, North America Recombinant Human Chorionic Gonadotropin Market Size Market Share
8.5 Europe
8.5.1 Europe Recombinant Human Chorionic Gonadotropin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Recombinant Human Chorionic Gonadotropin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Recombinant Human Chorionic Gonadotropin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Recombinant Human Chorionic Gonadotropin Market Size Market Share
8.7 South America
8.7.1 South America Recombinant Human Chorionic Gonadotropin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Recombinant Human Chorionic Gonadotropin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Recombinant Human Chorionic Gonadotropin Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029
9.3 By Country, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.4.2 By Type, U.S. Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.5.2 By Type, Europe Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.6.2 By Type, China Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.7.2 By Type, Japan Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.8.2 By Type, South Korea Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.10.2 By Type, India Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Recombinant Human Chorionic Gonadotropin Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Ferring Pharmaceuticals
10.1.1 Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.1.2 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.1.3 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Ferring Pharmaceuticals Company Profile and Main Business
10.1.5 Ferring Pharmaceuticals Recent Developments
10.2 Schering Plough
10.2.1 Schering Plough Company Information, Head Office, Market Area, and Industry Position
10.2.2 Schering Plough Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.2.3 Schering Plough Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Schering Plough Company Profile and Main Business
10.2.5 Schering Plough Recent Developments
10.3 Serum International Ltd
10.3.1 Serum International Ltd Company Information, Head Office, Market Area, and Industry Position
10.3.2 Serum International Ltd Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.3.3 Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Serum International Ltd Company Profile and Main Business
10.3.5 Serum International Ltd Recent Developments
10.4 Merck
10.4.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.4.2 Merck Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.4.3 Merck Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Merck Company Profile and Main Business
10.4.5 Merck Recent Developments
10.5 Wellona Pharma
10.5.1 Wellona Pharma Company Information, Head Office, Market Area, and Industry Position
10.5.2 Wellona Pharma Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.5.3 Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Wellona Pharma Company Profile and Main Business
10.5.5 Wellona Pharma Recent Developments
10.6 Bionomics Lifesciences
10.6.1 Bionomics Lifesciences Company Information, Head Office, Market Area, and Industry Position
10.6.2 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.6.3 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Bionomics Lifesciences Company Profile and Main Business
10.6.5 Bionomics Lifesciences Recent Developments
10.7 Marvel Oceanic Private Limited
10.7.1 Marvel Oceanic Private Limited Company Information, Head Office, Market Area, and Industry Position
10.7.2 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.7.3 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Marvel Oceanic Private Limited Company Profile and Main Business
10.7.5 Marvel Oceanic Private Limited Recent Developments
10.8 Facmed Pharmaceuticals
10.8.1 Facmed Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.8.2 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
10.8.3 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Facmed Pharmaceuticals Company Profile and Main Business
10.8.5 Facmed Pharmaceuticals Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Recombinant Human Chorionic Gonadotropin Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Recombinant Human Chorionic Gonadotropin Market Restraints
Table 3. Recombinant Human Chorionic Gonadotropin Market Trends
Table 4. Recombinant Human Chorionic Gonadotropin Industry Policy
Table 5. Global Recombinant Human Chorionic Gonadotropin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Recombinant Human Chorionic Gonadotropin Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Recombinant Human Chorionic Gonadotropin Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Recombinant Human Chorionic Gonadotropin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Recombinant Human Chorionic Gonadotropin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Recombinant Human Chorionic Gonadotropin Mergers & Acquisitions, Expansion Plans
Table 12. Global Recombinant Human Chorionic Gonadotropin Manufacturers Product Type
Table 13. Head Office and Recombinant Human Chorionic Gonadotropin Production Site of Key Manufacturer
Table 14. Recombinant Human Chorionic Gonadotropin Capacity of Major Manufacturers and Future Plan
Table 15. China Recombinant Human Chorionic Gonadotropin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Recombinant Human Chorionic Gonadotropin Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Recombinant Human Chorionic Gonadotropin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Recombinant Human Chorionic Gonadotropin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Recombinant Human Chorionic Gonadotropin Production by Region, 2018-2023, (K Units)
Table 20. Global Recombinant Human Chorionic Gonadotropin Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Recombinant Human Chorionic Gonadotropin Upstream (Raw Materials)
Table 22. Global Recombinant Human Chorionic Gonadotropin Typical Customers
Table 23. Recombinant Human Chorionic Gonadotropin Typical Distributors
Table 24. By Type, Global Recombinant Human Chorionic Gonadotropin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Recombinant Human Chorionic Gonadotropin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Recombinant Human Chorionic Gonadotropin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2018-2029
Table 34. Ferring Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 35. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 36. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Ferring Pharmaceuticals Company Profile and Main Business
Table 38. Ferring Pharmaceuticals Recent Developments
Table 39. Schering Plough Company Information, Head Office, Market Area, and Industry Position
Table 40. Schering Plough Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 41. Schering Plough Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Schering Plough Company Profile and Main Business
Table 43. Schering Plough Recent Developments
Table 44. Serum International Ltd Company Information, Head Office, Market Area, and Industry Position
Table 45. Serum International Ltd Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 46. Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Serum International Ltd Company Profile and Main Business
Table 48. Serum International Ltd Recent Developments
Table 49. Merck Company Information, Head Office, Market Area, and Industry Position
Table 50. Merck Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 51. Merck Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Merck Company Profile and Main Business
Table 53. Merck Recent Developments
Table 54. Wellona Pharma Company Information, Head Office, Market Area, and Industry Position
Table 55. Wellona Pharma Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 56. Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Wellona Pharma Company Profile and Main Business
Table 58. Wellona Pharma Recent Developments
Table 59. Bionomics Lifesciences Company Information, Head Office, Market Area, and Industry Position
Table 60. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 61. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Bionomics Lifesciences Company Profile and Main Business
Table 63. Bionomics Lifesciences Recent Developments
Table 64. Marvel Oceanic Private Limited Company Information, Head Office, Market Area, and Industry Position
Table 65. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 66. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Marvel Oceanic Private Limited Company Profile and Main Business
Table 68. Marvel Oceanic Private Limited Recent Developments
Table 69. Facmed Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 70. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Models, Specifications, and Application
Table 71. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Facmed Pharmaceuticals Company Profile and Main Business
Table 73. Facmed Pharmaceuticals Recent Developments
List of Figures
Figure 1. Recombinant Human Chorionic Gonadotropin Picture
Figure 2. Global Recombinant Human Chorionic Gonadotropin Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Recombinant Human Chorionic Gonadotropin Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Recombinant Human Chorionic Gonadotropin Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Recombinant Human Chorionic Gonadotropin Sales Quantity (K Units) & (2018-2029)
Figure 7. China Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Recombinant Human Chorionic Gonadotropin Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Recombinant Human Chorionic Gonadotropin Market Share of Global, 2018-2029
Figure 10. Global Recombinant Human Chorionic Gonadotropin Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Recombinant Human Chorionic Gonadotropin Key Participants, Market Share, 2022
Figure 12. Global Recombinant Human Chorionic Gonadotropin Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Recombinant Human Chorionic Gonadotropin Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Recombinant Human Chorionic Gonadotropin Production Market Share & Forecast by Region, 2018-2029
Figure 15. Recombinant Human Chorionic Gonadotropin Industry Chain
Figure 16. Recombinant Human Chorionic Gonadotropin Procurement Model
Figure 17. Recombinant Human Chorionic Gonadotropin Sales Model
Figure 18. Recombinant Human Chorionic Gonadotropin Sales Channels, Direct Sales, and Distribution
Figure 19. Intramuscular Powder for Injection
Figure 20. Subcutaneous Solution for Injection
Figure 21. By Type, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Female
Figure 27. Male
Figure 28. By Application, Global Recombinant Human Chorionic Gonadotropin Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Recombinant Human Chorionic Gonadotropin Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2018-2029
Figure 35. North America Recombinant Human Chorionic Gonadotropin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2022
Figure 37. Europe Recombinant Human Chorionic Gonadotropin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2022
Figure 39. Asia Pacific Recombinant Human Chorionic Gonadotropin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2022
Figure 41. South America Recombinant Human Chorionic Gonadotropin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Recombinant Human Chorionic Gonadotropin Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Recombinant Human Chorionic Gonadotropin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 50. China Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 62. India Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches
Research Methodology:
Recombinant Human Chorionic Gonadotropin Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|